These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15345373)

  • 1. Toxicogenomics in risk assessment: communicating the challenges.
    Pettit SD
    Environ Health Perspect; 2004 Aug; 112(12):A662. PubMed ID: 15345373
    [No Abstract]   [Full Text] [Related]  

  • 2. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
    Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicogenomics through the eyes of informatics: conference overview and recommendations.
    Olden K; Call N; Sobral B; Oakes R
    Environ Health Perspect; 2004 May; 112(7):805-7. PubMed ID: 15159210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD).
    Mattingly CJ; Colby GT; Rosenstein MC; Forrest JN; Boyer JL
    Pharmacogenomics J; 2004; 4(1):5-8. PubMed ID: 14735110
    [No Abstract]   [Full Text] [Related]  

  • 5. Taking stock of toxicogenomics: mini-monograph offers overview.
    Hood E
    Environ Health Perspect; 2004 Mar; 112(4):A231. PubMed ID: 15040318
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxicogenomics: A 2020 Vision.
    Liu Z; Huang R; Roberts R; Tong W
    Trends Pharmacol Sci; 2019 Feb; 40(2):92-103. PubMed ID: 30594306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicogenomics in genetic toxicology and hazard determination--concluding remarks.
    Sarrif A; van Delft JH; Gant TW; Kleinjans JC; van Vliet E
    Mutat Res; 2005 Aug; 575(1-2):116-7. PubMed ID: 15924887
    [No Abstract]   [Full Text] [Related]  

  • 8. Toxicogenomics in drug safety assessment.
    Hewitt P; Walijew A
    Pharmacogenomics; 2008 Apr; 9(4):379-82. PubMed ID: 18384252
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers to the use of toxicogenomics data in human health risk assessment: A survey of Canadian risk assessors.
    Vachon J; Campagna C; Rodriguez MJ; Sirard MA; Levallois P
    Regul Toxicol Pharmacol; 2017 Apr; 85():119-123. PubMed ID: 28137640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicogenomics in drug discovery and drug development: potential applications and future challenges.
    Khor TO; Ibrahim S; Kong AN
    Pharm Res; 2006 Aug; 23(8):1659-64. PubMed ID: 16858654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The state-of-the-art in predictive toxicogenomics.
    Fielden MR; Kolaja KL
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):84-91. PubMed ID: 16445120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicogenomics in genetic toxicology and hazard determination: introduction and overview.
    Sarrif A; van Delft JH; van Schooten FJ; Gant TW; Elliott BM; van Ravenzwaay B; van Steeg H; Vrijhof H
    Mutat Res; 2005 Aug; 575(1-2):1-3. PubMed ID: 15924883
    [No Abstract]   [Full Text] [Related]  

  • 13. Drawing comparisons at Duke.
    Hood E
    Environ Health Perspect; 2004 May; 112(7):A408-9. PubMed ID: 15159213
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in toxicogenomics.
    Hayes KR; Bradfield CA
    Chem Res Toxicol; 2005 Mar; 18(3):403-14. PubMed ID: 15777080
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of applying toxicogenomics to increase the efficiency of drug discovery.
    Barros SA
    Pharmacogenomics; 2005 Sep; 6(6):547-50. PubMed ID: 16142994
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicogenomics data: the road to acceptance.
    Freeman K
    Environ Health Perspect; 2004 Aug; 112(12):A678-85. PubMed ID: 15345379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomics in drug discovery: from preclinical studies to clinical trials.
    Yang Y; Blomme EA; Waring JF
    Chem Biol Interact; 2004 Nov; 150(1):71-85. PubMed ID: 15522262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine.
    Youns M; Hoheisel JD; Efferth T
    Planta Med; 2010 Dec; 76(17):2019-25. PubMed ID: 20957595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future prospects of toxicogenomics in drug discovery.
    Khan SR; Baghdasarian A; Fahlman RP; Michail K; Siraki AG
    Drug Discov Today; 2014 May; 19(5):562-78. PubMed ID: 24216320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Toxicogenomics. New perspectives for the molecular toxicology].
    Lutz W; Kur B
    Med Pr; 2004; 55(2):193-202. PubMed ID: 15524089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.